Syntax Bio's discovery platform overcomes the longstanding challenges in stem cell-derived therapies by directly controlling and accelerating cell differentiation. A shorter and more reliable cell differentiation process improves patient access by making discovery faster, less costly and scalable. Synatx’s proprietary Cellgorithm technology mimics human development using a sequential CRISPR-based system to generate a wide diversity of functional cell types to enable new product opportunities.

Biotechnology

Life Sciences

Therapeutics

Syntax Bio

The Chicago office focuses on scientific research and technological innovation to drive advancements in the biotech sector.

Chicago

John Flavin

Nick Timmins

Brad Merrill

Ryan Clarke

This department provides strategic direction and governance for the organization.

Executive Leadership

This department focuses on providing high-level strategic guidance and advice to drive organizational goals.

Strategic Affairs

This department conducts scientific research and develops innovative products and solutions.

Syntax Bio

Org chart

Teams

Executive Leadership

Strategic Affairs

Research and Development

Offices